Brokerages Set Sotera Health (NASDAQ:SHC) Target Price at $16.08

Sotera Health (NASDAQ:SHC) has earned an average rating of “Moderate Buy” from the seven ratings firms that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $16.08.

Several analysts have recently commented on SHC shares. Citigroup raised their target price on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, November 6th. The Goldman Sachs Group assumed coverage on Sotera Health in a report on Friday, December 6th. They issued a “neutral” rating and a $14.00 target price for the company. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $17.00 price target on shares of Sotera Health in a research note on Thursday, November 21st.

Sotera Health Trading Down 1.9 %

NASDAQ SHC opened at $13.15 on Monday. The firm’s fifty day moving average price is $14.61 and its 200 day moving average price is $14.14. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The company has a market capitalization of $3.72 billion, a price-to-earnings ratio of 52.60 and a beta of 1.96.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The business had revenue of $285.47 million during the quarter, compared to analysts’ expectations of $278.64 million. During the same quarter last year, the company earned $0.18 EPS. The firm’s revenue for the quarter was up 8.5% compared to the same quarter last year. On average, sell-side analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Darsana Capital Partners LP raised its position in shares of Sotera Health by 716.9% during the 3rd quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock worth $334,167,000 after purchasing an additional 17,560,636 shares during the last quarter. Sessa Capital IM L.P. increased its position in Sotera Health by 46.5% during the third quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after buying an additional 2,000,000 shares in the last quarter. State Street Corp raised its holdings in shares of Sotera Health by 18.5% in the third quarter. State Street Corp now owns 4,126,806 shares of the company’s stock worth $68,918,000 after acquiring an additional 644,236 shares during the last quarter. AQR Capital Management LLC lifted its position in shares of Sotera Health by 3,198.2% in the second quarter. AQR Capital Management LLC now owns 511,580 shares of the company’s stock valued at $6,072,000 after acquiring an additional 496,069 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in shares of Sotera Health by 19.4% during the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after acquiring an additional 447,186 shares during the last quarter. Institutional investors and hedge funds own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.